Published in PLoS One on January 24, 2014
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78
Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One (2016) 0.78
Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan. Medicine (Baltimore) (2016) 0.75
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation (2008) 2.48
Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25
Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00
Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med (2005) 1.55
Current status and future of liver transplantation. Semin Liver Dis (2010) 1.40
Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation (2012) 1.31
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology (2008) 1.30
De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14
Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant (2003) 1.13
De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl (2009) 1.09
De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant (2004) 1.09
De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl (2005) 1.07
Depressed immunity and the development of cancer. Cancer Detect Prev (1994) 1.04
De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc (2012) 1.01
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis (2009) 1.01
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99
Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl (2001) 0.98
Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer (1998) 0.97
Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Transpl Int (2013) 0.94
Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transpl (2011) 0.93
Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant (2012) 0.93
De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan. Transplant Proc (2004) 0.92
De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant (2013) 0.91
De novo malignancies after renal transplantation--a single-center experience in the Balkans. Transplant Proc (2007) 0.90
De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc (2013) 0.88
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation (2013) 0.85
Recurrent nonhepatic and de novo malignancies after liver transplantation. Transplantation (2009) 0.81
Skin cancers after liver transplantation: what to do? J Hepatol (2005) 0.81
Malignancy after liver transplantation in patients with premalignant conditions. J Clin Gastroenterol (2003) 0.80